Clinical Trial: A Single-arm, Phase II Clinical Trial of ASPIRin to PrEvent Venous Thromboembolism in Patients with Advanced Germ Cell Tumors Receiving Chemotherapy

U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06866964) titled 'A Single-arm, Phase II Clinical Trial of ASPIRin to PrEvent Venous Thromboembolism in Patients with Advanced Germ Cell Tumors Receiving Chemotherapy' on March 04.

Brief Summary: The purpose of this study is to the 6-month Venous Thromboembolism (VTE)-free rate in participants with advanced germ cell cancer at high risk of VTE who are receiving standard of care cisplatin-based chemotherapy and low-dose acetylsalicylic acid (ASA) and compare to relevant historical controls

Study Start Date: May, 2025

Study Type: INTERVENTIONAL

Condition: Germ Cell Tumor Testicular Cancer

Intervention: DRUG: Low-dose ASA

81 mg by mouth daily fo...